{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:56:33Z","timestamp":1793372193865,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,2,4]],"date-time":"2015-02-04T00:00:00Z","timestamp":1423008000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jctejournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical & Translational Endocrinology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jcte.2015.02.001","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T22:51:39Z","timestamp":1423608699000},"page":"77-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals"],"prefix":"10.1016","volume":"2","author":[{"given":"Lynae J.","family":"Hanks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6593-3571","authenticated-orcid":false,"given":"Orlando M.","family":"Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcas M.","family":"Bamman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambika","family":"Ashraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth L.","family":"McCormick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Casazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcte.2015.02.001_bib1","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1016\/j.febslet.2008.10.021","article-title":"FGF21 is an Akt-regulated myokine","volume":"582","author":"Izumiya","year":"2008","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jcte.2015.02.001_bib2","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.2337\/db09-0713","article-title":"Fibroblast growth factor-21 is induced in human skeletal muscles by hyperinsulinemia","volume":"58","author":"Hojman","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2015.02.001_bib3","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI23606","article-title":"FGF-21 as a novel metabolic regulator","volume":"115","author":"Kharitonenkov","year":"2005","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcte.2015.02.001_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jcp.20847","article-title":"Molecular determinants of FGF-21 activity-synergy and cross-talk with PPARgamma signaling","volume":"210","author":"Moyers","year":"2007","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.jcte.2015.02.001_bib5","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.2337\/db05-1435","article-title":"Fibroblast growth factor-21 improves pancreatic beta-cell function and survival by activation of extracellular signal-regulated kinase 1\/2 and Akt signaling pathways","volume":"55","author":"Wente","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2015.02.001_bib6","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.cmet.2007.05.002","article-title":"Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states","volume":"5","author":"Badman","year":"2007","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcte.2015.02.001_bib7","doi-asserted-by":"crossref","first-page":"e00065","DOI":"10.7554\/eLife.00065","article-title":"The starvation hormone, fibroblast growth factor-21, extends lifespan in mice","volume":"1","author":"Zhang","year":"2012","journal-title":"Elife"},{"key":"10.1016\/j.jcte.2015.02.001_bib8","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.2337\/db07-1476","article-title":"Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans","volume":"57","author":"Zhang","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/j.jcte.2015.02.001_bib9","doi-asserted-by":"crossref","first-page":"E469","DOI":"10.1152\/ajpendo.00330.2013","article-title":"Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine","volume":"306","author":"Keipert","year":"2014","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.jcte.2015.02.001_bib10","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cmet.2008.06.014","article-title":"The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man","volume":"8","author":"Galman","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/j.jcte.2015.02.001_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1687-9856-2014-7","article-title":"Significant gender difference in serum levels of fibroblast growth factor 21 in Danish children and adolescents","volume":"2014","author":"Bisgaard","year":"2014","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.1016\/j.jcte.2015.02.001_bib12","first-page":"71","article-title":"Getting to the height of the matter: the relationship between stature and adiposity in pre-pubertal children","volume":"23","author":"Hanks","year":"2013","journal-title":"Ethn Dis"},{"key":"10.1016\/j.jcte.2015.02.001_bib13","article-title":"Fibroblast growth factor-21, body composition, and insulin resistance in pre-pubertal and early pubertal males and females","author":"Hanks","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.jcte.2015.02.001_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.bone.2011.08.032","article-title":"Short-term physical activity intervention decreases femoral bone marrow adipose tissue in young children: a pilot study","volume":"50","author":"Casazza","year":"2012","journal-title":"Bone"},{"key":"10.1016\/j.jcte.2015.02.001_bib15","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/bonekey.2013.49","article-title":"The relationships among total body fat, bone mineral content and bone marrow adipose tissue in early-pubertal girls","volume":"2","author":"Newton","year":"2013","journal-title":"Bonekey Rep"},{"key":"10.1016\/j.jcte.2015.02.001_bib16","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1152\/japplphysiol.00019.2013","article-title":"Heightened muscle inflammation susceptibility may impair regenerative capacity in aging humans","volume":"115","author":"Merritt","year":"2013","journal-title":"J\u00a0Appl Physiol (1985)"},{"key":"10.1016\/j.jcte.2015.02.001_bib17","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1249\/MSS.0b013e318207c15d","article-title":"Exercise dosing to retain resistance training adaptations in young and older adults","volume":"43","author":"Bickel","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.jcte.2015.02.001_bib18","series-title":"CDC growth charts","year":"2009"},{"issue":"11","key":"10.1016\/j.jcte.2015.02.001_bib19","doi-asserted-by":"crossref","first-page":"E2198","DOI":"10.1210\/jc.2014-1566","article-title":"Elevated FGF21 leads to attenuated postnatal linear growth in preterm infants through GH resistance in chondrocytes","volume":"99","author":"Guasti","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2015.02.001_bib20","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.metabol.2011.10.012","article-title":"Association between serum fibroblast growth factor 21 and diabetic nephropathy","volume":"61","author":"Jian","year":"2012","journal-title":"Metabolism"},{"key":"10.1016\/j.jcte.2015.02.001_bib21","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1210\/jc.2011-2823","article-title":"Relationship of serum fibroblast growth factor 21 with abnormal glucose metabolism and insulin resistance: the Baltimore longitudinal study of aging","volume":"97","author":"Semba","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2015.02.001_bib22","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3389\/fendo.2014.00107","article-title":"FGF21 as a Hepatokine, Adipokine, and Myokine in Metabolism and Diseases","volume":"5","author":"Itoh","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcte.2015.02.001_bib23","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fendo.2013.00194","article-title":"Stressed liver and muscle call on adipocytes with FGF21","volume":"4","author":"Luo","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jcte.2015.02.001_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-2007-985148","article-title":"Circulating FGF-21 levels in normal subjects and in newly diagnose patients with type 2 diabetes mellitus","volume":"116","author":"Chen","year":"2008","journal-title":"Exp Clin Endocrinol Diabetes"},{"issue":"10","key":"10.1016\/j.jcte.2015.02.001_bib25","doi-asserted-by":"crossref","first-page":"E1877","DOI":"10.1210\/jc.2014-1877","article-title":"Cardiorespiratory fitness and visceral fat are key determinants of serum fibroblast growth factor 21 concentration in Japanese men","volume":"99","author":"Taniguchi","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.jcte.2015.02.001_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/joim.12348","article-title":"Bone and the regulation of global energy balance","author":"Zhang","year":"2015","journal-title":"J\u00a0Intern Med"},{"key":"10.1016\/j.jcte.2015.02.001_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev.pharmtox.40.1.491","article-title":"Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators","volume":"40","author":"Corton","year":"2000","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jcte.2015.02.001_bib28","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bone.2013.06.016","article-title":"Determinants of bone marrow adiposity: the modulation of peroxisome proliferator-activated receptor-gamma2 activity as a central mechanism","volume":"56","author":"Sadie-Van Gijsen","year":"2013","journal-title":"Bone"},{"key":"10.1016\/j.jcte.2015.02.001_bib29","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1615\/CritRevEukarGeneExpr.v19.i2.20","article-title":"Marrow fat and the bone microenvironment: developmental, functional, and pathological implications","volume":"19","author":"Rosen","year":"2009","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/j.jcte.2015.02.001_bib30","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/34184","article-title":"PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines","volume":"391","author":"Jiang","year":"1998","journal-title":"Nature"}],"container-title":["Journal of Clinical & Translational Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623715000472?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214623715000472?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:52:01Z","timestamp":1762005121000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214623715000472"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S2214623715000472"],"URL":"https:\/\/doi.org\/10.1016\/j.jcte.2015.02.001","relation":{},"ISSN":["2214-6237"],"issn-type":[{"value":"2214-6237","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Circulating levels of fibroblast growth factor-21 increase with age independently of body composition indices among healthy individuals","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical & Translational Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcte.2015.02.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}